» Authors » Meyer D Glantz

Meyer D Glantz

Explore the profile of Meyer D Glantz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 879
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bharat C, Glantz M, Aguilar-Gaxiola S, Alonso J, Bruffaerts R, Bunting B, et al.
Addiction . 2023 Jan; 118(5):954-966. PMID: 36609992
Aims: Likelihood of alcohol dependence (AD) is increased among people who transition to greater levels of alcohol involvement at a younger age. Indicated interventions delivered early may be effective in...
2.
Degenhardt L, Bharat C, Glantz M, Bromet E, Alonso J, Bruffaerts R, et al.
Drug Alcohol Depend . 2022 Sep; 240:109574. PMID: 36150948
Aim: Exposure to traumatic events (TEs) is associated with substance use disorders (SUDs). However, most studies focus on a single TE, and are limited to single countries, rather than across...
3.
Barch D, Albaugh M, Baskin-Sommers A, Bryant B, Clark D, Dick A, et al.
Dev Cogn Neurosci . 2021 Nov; 52:101031. PMID: 34742018
The Adolescent Brain Cognitive Development (ABCD) Study of 11,880 youth incorporates a comprehensive range of measures assessing predictors and outcomes related to mental health across childhood and adolescence in participating...
4.
Bonar E, Kidwell K, Bohnert A, Bourque C, Carter P, Clark S, et al.
Contemp Clin Trials . 2021 Aug; 108:106523. PMID: 34352386
Preventing opioid misuse and opioid use disorder is critical among at-risk adolescents and young adults (AYAs). An Emergency Department (ED) visit provides an opportunity for delivering interventions during a rapidly...
5.
Glantz M, Bharat C, Degenhardt L, Sampson N, Scott K, Lim C, et al.
Addict Behav . 2020 Mar; 106:106381. PMID: 32209298
No abstract available.
6.
Glantz M, Bharat C, Degenhardt L, Sampson N, Scott K, Lim C, et al.
Addict Behav . 2019 Dec; 102:106128. PMID: 31865172
Background: Prevalences of Alcohol Use Disorders (AUDs) and Mental Health Disorders (MHDs) in many individual countries have been reported but there are few cross-national studies. The WHO World Mental Health...
7.
Degenhardt L, Bharat C, Glantz M, Sampson N, Scott K, Lim C, et al.
Int J Drug Policy . 2019 Jul; 71:103-112. PMID: 31255918
Background: Illicit drug use and associated disease burden are estimated to have increased over the past few decades, but large gaps remain in our knowledge of the extent of use...
8.
Glantz M
Alcohol Clin Exp Res . 2019 Jun; 43(9):1823-1828. PMID: 31237982
No abstract available.
9.
Degenhardt L, Bharat C, Glantz M, Sampson N, Al-Hamzawi A, Alonso J, et al.
JAMA Psychiatry . 2019 Mar; 76(7):708-720. PMID: 30865282
Importance: Limited empirical research has examined the extent to which cohort-level prevalence of substance use is associated with the onset of drug use and transitioning into greater involvement with drug...
10.
Harris M, Bharat C, Glantz M, Sampson N, Al-Hamzawi A, Alonso J, et al.
Addiction . 2019 Mar; 114(8):1446-1459. PMID: 30835879
Aims: To examine cross-national patterns of 12-month substance use disorder (SUD) treatment and minimally adequate treatment (MAT), and associations with mental disorder comorbidity. Design: Cross-sectional, representative household surveys. Setting: Twenty-seven...